Dr. Yang has over 10 years of experience in medicinal chemistry and CMC development. She received her PhD in organic chemistry from the University of Manchester, UK. Her PhD research focused on gold catalysis and bifuncational organo-catalysis. After graduation, she joined GSK to start her medicinal chemistry career, where she contributed to multiple targets in neuroscience, and was involved in various stages of drug discovery efforts, from HTS to LO to PCC. In 2017, she joined Bellen, as Director/VP in Shanghai R&D center. She also led Bellen’s process safety evaluation team. In 2019, she was recruited to Cullgen as Director of medicinal and process chemistry. Dr. Yang has published 19 peer-reviewed journal articles. She is also an inventor of 14 issued patent applications.
Upgrade to view 0 reports
This person is not in any offices
Cullgen
Cullgen is a biopharmaceutical company that has developed protein degradation technology that utilizes the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.